跳至主要内容
临床试验/IRCT20190630044057N1
IRCT20190630044057N1招募中3 期

The effect of melatonin on incidence and severity of arthralgia-myalgia caused by weekly paclitaxel in patients with breast cancer

Tehran University of Medical Sciences0 个研究点目标入组 62 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Women with Breast Cancer and Candidate receiving Paclitaxel 80 mg / m 2 weekly for 12 weeks after doxorubicin + cyclophosphamide regimen
  • Age over 18 years
  • Ability to take oral medication
  • Ability to fill out a questionnaire
  • Not taking pain relief medication for chronic
  • No peripheral neuropathy
  • No history of fibromyalgia, Rheumatoid arthritis, Osteoarthritis
  • No history of receiving paclitaxel or any other drug with neurotoxicity
  • Uncontrolled diabetes
  • no history of receiving alcohol, statin, colchicine, zidovudine, penicillamine.
  • no history of metastatic disease

排除标准

  • Patients with concurrent GCSF administration
  • Patients who experience trauma or falling during the study
  • Viral Respiratory Infection During Study

研究者

相似试验